Masayoshi Son, SoftBank CEO (glen photo/Shutterstock)

Japan's Soft­Bank plots bil­lions in biotech in­vest­ments in move that could keep the val­u­a­tion flood ris­ing — re­port

The val­u­a­tion crazy train in biotech con­tin­ues to roll in­to the new year with more than a dozen com­pa­nies tak­ing a chance on Nas­daq and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.